Sobell Department of Motor Neuroscience
University College London Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square
London, United Kingdom
Professor Tom Foltynie is Consultant Neurologist at the Sobell Department of Motor Neuroscience at the UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London. He completed Neurology training in Cambridge where he undertook his Ph.D. in the epidemiology and genetics of Parkinson’s disease. He is responsible for Movement disorder patients, particularly PD patients undergoing advanced treatments such as DBS, Apomorphine and Duodopa. He is chief investigator for a trial of Exenatide- a potential neurorestorative treatment for PD, as well as the lead clinician at UCL for a multi-centre trial of fetal dopaminergic cell transplantation for PD, and a proposed trial of Deep Brain stimulation as a treatment for the cognitive problems associated with advanced PD. Dr Foltynie is also leading a trial of Deep Brain Stimulation for the treatment of patients with severe Tourette syndrome. Aside from trial involvement, PD patients with and without DBS are being recruited to research looking at the influence of genetics on PD risk and clinical progression, and the use of functional imaging to explore the mechanism of action of DBS surgery.